| Product NDC: | 64679-810 |
| Proprietary Name: | Baycadron |
| Non Proprietary Name: | Dexamethasone |
| Active Ingredient(s): | .5 mg/5mL & nbsp; Dexamethasone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | ELIXIR |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64679-810 |
| Labeler Name: | Wockhardt USA, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA088254 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19830727 |
| Package NDC: | 64679-810-08 |
| Package Description: | 30 mL in 1 BOTTLE (64679-810-08) |
| NDC Code | 64679-810-08 |
| Proprietary Name | Baycadron |
| Package Description | 30 mL in 1 BOTTLE (64679-810-08) |
| Product NDC | 64679-810 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dexamethasone |
| Dosage Form Name | ELIXIR |
| Route Name | ORAL |
| Start Marketing Date | 19830727 |
| Marketing Category Name | ANDA |
| Labeler Name | Wockhardt USA, LLC |
| Substance Name | DEXAMETHASONE |
| Strength Number | .5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |